Levonova

Levonova: an effective contraceptive and therapeutic agent for idiopathic menorrhagia

Levonova is a monohormonal oral contraceptive produced by a pharmaceutical group from Finland. Its active ingredient, levonorgestrel, is a synthetic analogue of the female sex hormone progesterone. Levonova is a polymer carrier containing levonorgestrel, which provides prolonged release of the hormone into the body.

The main indication for the use of Levonova is contraception. However, the drug can also be used to treat idiopathic menorrhagia (abnormal blood flow from the uterus not associated with organic changes). The levonorgestrel intrauterine system, also known as Mirena, can be used to treat menorrhagia.

Despite its effectiveness and widespread use, Levonova has a number of contraindications. The drug is not recommended for hypersensitivity to levonorgestrel, hormone-dependent tumors, a tendency to thromboembolism, otosclerosis, acute diseases or liver tumors, infectious diseases of the genitourinary system, pregnancy and lactation.

Like any other medicine, Levonova may cause some side effects. Rarely, intermenstrual bleeding, menstrual irregularities, mastalgia, hair loss, dermatitis, nausea, headache, acne, fluid retention, hirsutism and depression occur.

There is no data yet on the interaction of Levonova with other medications. There is also no data on overdose. However, with prolonged intermenstrual bleeding, additional examination is necessary to clarify the diagnosis.

In conclusion, Levonova is an effective and easy-to-use contraceptive and treatment for idiopathic menorrhagia. However, before using this drug, you should consult a doctor and read the instructions for use to avoid possible undesirable consequences.